Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances in targeting protein kinases and pseudokinases in cancer biology. | Front Cell Dev Biol | 2022 | 35938171 | PubTator, text mining | PubMed |
| CircRNA-Encoded Peptides or Proteins as New Players in Digestive System Neoplasms. | Front Oncol | 2022 | 35936754 | PubTator, text mining | PubMed |
| Genomic Landscape of RTK/RAS Pathway and Tumor Immune Infiltration as Prognostic Indicator of Lung Adenocarcinoma. | Front Oncol | 2022 | 35936718 | PubTator, text mining | PubMed |
| Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells. | Front Chem | 2022 | 35936102 | PubTator, text mining | PubMed |
| Primary gliosarcoma with widespread extracranial metastases-spatiotemporal morphological variation. | Chin Neurosurg J | 2022 | 35932030 | PubTator, text mining | PubMed |
| Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies. | Reprod Fertil | 2022 | 35928672 | PubTator, text mining | PubMed |
| The Evolution of BRAF Activation in Non-Small-Cell Lung Cancer. | Front Oncol | 2022 | 35912223 | PubTator, text mining | PubMed |
| Spectrum of BRAF Aberrations and Its Potential Clinical Implications: Insights From Integrative Pan-Cancer Analysis. | Front Bioeng Biotechnol | 2022 | 35910024 | PubTator, text mining | PubMed |
| lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization. | Research (Wash D C) | 2022 | 35909936 | PubTator, text mining | PubMed |
| Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation. | Cancer Discov | 2022 | 35904492 | PubTator, text mining | PubMed |
| ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled? | Front Cell Dev Biol | 2022 | 35903549 | PubTator, text mining | PubMed |
| The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. | Front Genet | 2022 | 35903358 | PubTator, text mining | PubMed |
| Genomic Predictors of Recurrence Patterns After Complete Resection of Colorectal Liver Metastases and Adjuvant Hepatic Artery Infusion Chemotherapy. | Ann Surg Oncol | 2022 | 35896920 | PubTator, text mining | PubMed |
| Oxidative Stress in Chronic Hepatitis B-An Update. | Microorganisms | 2022 | 35888983 | PubTator, text mining | PubMed |
| Target-Based Small Molecule Drug Discovery for Colorectal Cancer: A Review of Molecular Pathways and In Silico Studies. | Biomolecules | 2022 | 35883434 | PubTator, text mining | PubMed |
| Somatic mutation analysis of Mesonephric-Like adenocarcinoma and associated putative precursor Lesions: Insight into pathogenesis and potential molecular treatment targets. | Gynecol Oncol Rep | 2022 | 35880223 | PubTator, text mining | PubMed |
| Endogenous spacing enables co-processing of microRNAs and efficient combinatorial RNAi. | Cell Rep Methods | 2022 | 35880017 | PubTator, text mining | PubMed |
| Spatial correlation of water distribution and fine structure of arabinoxylans in the developing wheat grain. | Carbohydr Polym | 2022 | 35868742 | PubTator, text mining | PubMed |
| Transcriptome Profiling of N7-Methylguanosine Modification of Messenger RNA in Drug-Resistant Acute Myeloid Leukemia. | Front Oncol | 2022 | 35865472 | PubTator, text mining | PubMed |
| Commonalities of Mycobacterium tuberculosis Transcriptomes in Response to Defined Persisting Macrophage Stresses. | Front Immunol | 2022 | 35844560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=22